EXPERT WITNESS CHILD ABUSE OU DEPARTMENT OF PEDIATRICS DR. MICHAEL BAXTER U.S. VS. DANIEL ASH (25-CR-00088)…
Award details are derived from public USAspending.gov records linked to this contractor. Not a bid recommendation.
Award details
- Award ID
- 15JA6225P00000019
- Contractor
- UNIVERSITY OF OKLAHOMA
- Awarding agency
- Department of Justice
- Sub-agency / office
- Offices, Boards and Divisions
- Award amount
- $1,600
- Period of performance
- May 12, 2025 – Jan 12, 2026
- Place of performance
- TULSA, OK, 741191056, USA
- Competition
- COMPETED UNDER SAP · Set-aside: NO SET ASIDE USED. · 1 offers
- Pricing
- TIME AND MATERIALS
- Financial breakdown
- Current value $1,600 · Obligated $1,600 · Potential value $1,600 · Latest action obligation $-6,029 · Outlays $1,600
Public award description
EXPERT WITNESS CHILD ABUSE OU DEPARTMENT OF PEDIATRICS DR. MICHAEL BAXTER U.S. VS. DANIEL ASH (25-CR-00088) AUSA ALICIA HOCKENBURY PERIOD OF PERFORMANCE: 05/12/2025-05/11/2026
Related intelligence
Related Federal Awards
- · 75N91022F00002 — TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE · INFORMATION MANAGEMENT SERVICES, INC. · Department of Health and Human Services · $1,435,788
- · 75N91025F00001 — BASE IDIQ TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE… · INFORMATION MANAGEMENT SERVICES, INC. · Department of Health and Human Services · $1,234,179
- · 75N92023F00001 — STRONG HEART STUDY (SHS)- OKLAHOMA UNIVERSITY HEALTH CENTER (OUHSC) COORDINATING CENTER(CC) SUBTASK B.2 - P… · DEFINITIVE LOGIC CORPORATION · Department of Health and Human Services · $1,218,378
- · 75N91022F00004 — CHEMOPREVENTION WITH MITOCHONDRIA-TARGETED HONOKIOL IN MOUSE MODELS OF LUNG CANCER: ADENOCARCINOMA AND SQUA… · INFORMATION MANAGEMENT SERVICES, INC. · Department of Health and Human Services · $1,201,554
- · 75N91026F00001 — TRIPLE NEGATIVE BREAST CANCER VACCINES · Department of Health and Human Services · $1,147,754
- · 75N91023F00001 — BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BI… · MEDIDATA SOLUTIONS, INC. · Department of Health and Human Services · $1,140,397